These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 9653875

  • 1. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats.
    Rimondini R, Ferré S, Giménez-Llort L, Ogren SO, Fuxe K.
    Eur J Pharmacol; 1998 Apr 24; 347(2-3):153-8. PubMed ID: 9653875
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680.
    Schindler CW, Karcz-Kubicha M, Thorndike EB, Müller CE, Tella SR, Goldberg SR, Ferré S.
    Eur J Pharmacol; 2004 Jan 26; 484(2-3):269-75. PubMed ID: 14744613
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum.
    Ferré S, Popoli P, Rimondini R, Reggio R, Kehr J, Fuxe K.
    Neuropharmacology; 1999 Jan 26; 38(1):129-40. PubMed ID: 10193904
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas.
    Pinna A, Wardas J, Cristalli G, Morelli M.
    Brain Res; 1997 Jun 06; 759(1):41-9. PubMed ID: 9219861
    [Abstract] [Full Text] [Related]

  • 11. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
    Arnt J, Bøgesø KP, Hyttel J, Meier E.
    Pharmacol Toxicol; 1988 Mar 06; 62(3):121-30. PubMed ID: 3259694
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
    Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7238-41. PubMed ID: 1678519
    [Abstract] [Full Text] [Related]

  • 15. Regulation of sensorimotor gating by interactions of dopamine and adenosine in the rat.
    Koch M, Hauber W.
    Behav Pharmacol; 1998 Feb 15; 9(1):23-9. PubMed ID: 9832945
    [Abstract] [Full Text] [Related]

  • 16. Behavioural responses to the selective D1-dopamine receptor agonist R-SK&F 38393 and the selective D2-agonist RU 24213 in young compared with aged rats.
    Molloy AG, Waddington JL.
    Br J Pharmacol; 1988 Oct 15; 95(2):335-42. PubMed ID: 2906555
    [Abstract] [Full Text] [Related]

  • 17. Activation of adenosine A₂A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation.
    Simola N, Costa G, Morelli M.
    Psychopharmacology (Berl); 2016 Feb 15; 233(3):507-19. PubMed ID: 26564233
    [Abstract] [Full Text] [Related]

  • 18. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
    Meller E, Bordi F, Bohmaker K.
    Life Sci; 1988 Feb 15; 42(25):2561-7. PubMed ID: 3260320
    [Abstract] [Full Text] [Related]

  • 19. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS, Joyce JN.
    Dev Psychobiol; 1998 May 15; 32(4):313-26. PubMed ID: 9589220
    [Abstract] [Full Text] [Related]

  • 20. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
    Ainsworth K, Smith SE, Sharp T.
    J Psychopharmacol; 1998 May 15; 12(3):252-7. PubMed ID: 10958251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.